文献速递眼整形与眼眶眼底病与葡萄膜炎

泪腺癌患者保留眼球手术联合辅助放疗后的视力结局与眼部并发症

Visual outcome and ocular complications in patients with lacrimal gland carcinoma after eye-sparing surgery and adjuvant radiation therapy.
PubMed 文献 · Br J Ophthalmol · 2023-11-22

该回顾性综述纳入2007至2018年间接受保留眼球手术联合辅助放疗或同步放化疗的23例泪腺癌连续患者,中位随访37个月。中位随访时57%患者最佳矫正视力达20/40或更好,30%为严重视力丧失;最常见眼部并发症为干眼病(91%)、放射性视网膜病变(70%)和白内障进展(49%)。肿瘤越过眶中线(p=0.014)和西班牙裔 ethnicity(p=0.014)与严重视力丧失风险增加相关。

要点

  • 保留眼球手术联合辅助放疗后57%患者最佳矫正视力≥20/40,30%为严重视力丧失。
  • 最常见并发症为干眼病(91%)、放射性视网膜病变(70%)和白内障进展(49%)。
  • 肿瘤越过眶中线和西班牙裔 ethnicity 与严重视力丧失风险增加相关(均 p=0.014)。

核心结论

  • 泪腺癌患者接受保留眼球手术联合辅助放疗后总体视力预后尚可。
  • 肿瘤越过眶中线的患者和西班牙裔患者发生严重视力丧失的风险更高。

研究设计与样本

  • 本综述纳入2007至2018年间接受保留眼球手术联合辅助放疗或同步放化疗的泪腺癌连续患者,共23例(15例男性、8例女性),中位年龄51岁。
  • 20例(87%)接受调强质子治疗,3例(13%)接受调强放射治疗;19例(83%)接受同步化疗。
  • 中位随访时间37个月(范围:8-83个月)。

主要发现

  • 中位随访37个月(范围:8-83个月)时,13例(57%)最佳矫正视力达20/40或更好,3例(13%)为中度视力丧失(20/40至20/200之间),7例(30%)为严重视力丧失(20/200或更差)。
  • 最常见眼部并发症为干眼病(21例;91%)、放射性视网膜病变(16例;70%)和白内障进展(11例;49%)。
  • 肿瘤越过眶中线(p=0.014)和西班牙裔 ethnicity(p=0.014)与严重视力丧失风险增加相关。
  • 放射性视网膜病变风险在三个种族组间有显著差异;西班牙裔患者(n=3)视网膜病变发生率最高(p<0.001)。
  • 肿瘤大小、初始T分期和总处方放射剂量与严重视力丧失无显著关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We report visual outcomes and ocular complications in patients with lacrimal gland carcinoma who had eye-sparing surgery followed by radiotherapy. METHODS: This review included consecutive patients with lacrimal gland carcinoma who underwent eye-sparing surgery and adjuvant radiotherapy or concurrent chemoradiation therapy between 2007 and 2018. Clinical data, including details of ophthalmological examinations and radiation treatment were reviewed. RESULTS: The study included 23 patients, 15 males and 8 females, with median age 51 years. Twenty patients (87%) received intensity-modulated proton therapy; 3 (13%) received intensity-modulated radiotherapy. Nineteen patients (83%) received concurrent chemotherapy. After a median follow-up time of 37 months (range: 8-83), 13 patients (57%) had best-corrected visual acuity 20/40 or better, 3 (13%) had moderate vision loss (between 20/40 and 20/200) and 7 (30%) had severe vision loss (20/200 or worse). The most common ocular complications were dry eye disease (21 patients; 91%), radiation retinopathy (16; 70%) and cataract progression (11; 49%). Tumour crossing the orbital midline (p=0.014) and Hispanic ethnicity (p=0.014) were associated with increased risk of severe vision loss. The risk of radiation retinopathy was significantly different among the three racial groups; Hispanic patients (n=3) had the highest rate of retinopathy (p<0.001). Tumour size, initial T category and total prescribed radiation dose were not significantly associated with severe vision loss. CONCLUSION: Eye-sparing surgery followed by adjuvant radiotherapy in patients with lacrimal gland carcinoma has a reasonable overall visual prognosis. Patients with tumours crossing the orbital midline and Hispanic patients have a higher risk of severe vision loss.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Zhao Z, Frank SJ, Ning J, et al. Visual outcome and ocular complications in patients with lacrimal gland carcinoma after eye-sparing surgery and adjuvant radiation therapy. Br J Ophthalmol. 2023. PMID: 36229179. doi:10.1136/bjo-2022-321889

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。